0001181431-12-007506.txt : 20120209
0001181431-12-007506.hdr.sgml : 20120209
20120209185556
ACCESSION NUMBER: 0001181431-12-007506
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120207
FILED AS OF DATE: 20120209
DATE AS OF CHANGE: 20120209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hung David
CENTRAL INDEX KEY: 0001310880
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32836
FILM NUMBER: 12588890
MAIL ADDRESS:
STREET 1: 501 SECOND STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MEDIVATION, INC.
CENTRAL INDEX KEY: 0001011835
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133863260
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 201 SPEAR STREET, 3RD FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
BUSINESS PHONE: 415-543-3470
MAIL ADDRESS:
STREET 1: 201 SPEAR STREET, 3RD FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
FORMER COMPANY:
FORMER CONFORMED NAME: ORION ACQUISITION CORP II
DATE OF NAME CHANGE: 19960408
4
1
rrd333558.xml
2/7/12 SALES
X0304
4
2012-02-07
0
0001011835
MEDIVATION, INC.
MDVN
0001310880
Hung David
C/O MEDIVATION, INC.
201 SPEAR STREET, 3RD FLOOR
SAN FRANCISCO
CA
94105
1
1
0
0
President and CEO
Common Stock
2012-02-07
4
S
0
4800
70.30
D
1209474
D
Common Stock
2012-02-07
4
S
0
14500
71.21
D
1194974
D
Common Stock
2012-02-07
4
S
0
23971
72.22
D
1171003
D
Common Stock
2012-02-07
4
S
0
100
73.01
D
1170903
D
Common Stock
2012-02-07
4
S
0
100
73.23
D
1170803
D
Common Stock
2012-02-08
4
S
0
22000
68.40
D
1148803
D
Common Stock
2012-02-08
4
S
0
28400
69.22
D
1120403
D
Common Stock
2012-02-08
4
S
0
4700
70.38
D
1115703
D
Common Stock
2012-02-08
4
S
0
1429
71.56
D
1114274
D
Common Stock
86060
I
By Trust
Shares sold pursuant to a 10b5-1 Plan.
The shares were sold at prices between $69.77 and $70.77. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices between $70.775 and $71.76. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices between $71.78 and $72.53. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices between $67.80 and $68.80. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices between $68.81 and $69.80. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices between $69.81 and $70.80. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices between $71.22 and $71.88. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
/s/ C. Patrick Machado, Attorney-in-fact
2012-02-09